Clinical Trials in Houston

Showing 6581-6600 of 17,885 trials

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

NCT06416059

The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.

Alcohol AbuseAnxiety

University of Houston50 participantsStarted May 2023

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

A Study of KRN23 in X-linked Hypophosphatemia

NCT00830674

The primary objective of this study is to assess the safety and tolerability of KRN23 after a single intravenous (IV) and subcutaneous (SC) administration in XLH patients.

X-linked Hypophosphatemia

Kyowa Kirin Co., Ltd.42 participantsStarted Dec 2008

New Haven, Connecticut, United States • Indianapolis, Indiana, United States • Durham, North Carolina, United States +1 more locations

TERMINATEDPhase 3< 1 mile

Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease

NCT03403205

The study will evaluate the efficacy and safety of ALXN1840 (formerly called WTX101) administered for 48 weeks compared to standard of care (SoC) in Wilson Disease (WD) participants aged 12 and older in the Primary Evaluation Period. In addition, efficacy and safety will be evaluated during an optional 60-month Extension Period.

Wilson Disease

Alexion Pharmaceuticals, Inc.214 participantsStarted Feb 2018

Los Angeles, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +53 more locations

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

A Study of KRN23 in X-linked Hypophosphatemia

Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease

Find Trials by Condition in Houston

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria